Preliminary physiologically based pharmacokinetic models for benzo[a]pyrene and dibenzo[def,p]chrysene in rodents
about
Cytochrome P450 1b1 in polycyclic aromatic hydrocarbon (PAH)-induced skin carcinogenesis: Tumorigenicity of individual PAHs and coal-tar extract, DNA adduction and expression of select genes in the Cyp1b1 knockout mouseComparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking waterPredicting lung dosimetry of inhaled particleborne benzo[a]pyrene using physiologically based pharmacokinetic modelingIn vitro metabolism of benzo[a]pyrene and dibenzo[def,p]chrysene in rodent and human hepatic microsomesHuman in Vivo Pharmacokinetics of [(14)C]Dibenzo[def,p]chrysene by Accelerator Mass Spectrometry Following Oral MicrodosingBenzo[a]pyrene-induced transcriptomic responses in primary hepatocytes and in vivo liver: toxicokinetics is essential for in vivo-in vitro comparisons.Transplacental carcinogenesis with dibenzo[def,p]chrysene (DBC): timing of maternal exposures determines target tissue response in offspring.Tissue Distribution, Excretion and Pharmacokinetics of the Environmental Pollutant Dibenzo[def,p]chrysene in Mice.Impact of pregnancy on the pharmacokinetics of dibenzo[def,p]chrysene in mice.Human Microdosing with Carcinogenic Polycyclic Aromatic Hydrocarbons: In Vivo Pharmacokinetics of Dibenzo[def,p]chrysene and Metabolites by UPLC Accelerator Mass Spectrometry.Dibenzo[def,p]chrysene (DBC) suppresses antibody formation in spleen cells following oral exposures of micePharmacokinetics of [14C]-Benzo[a]pyrene (BaP) in humans: Impact of Co-Administration of smoked salmon and BaP dietary restriction.Understanding the linked kinetics of benzo(a)pyrene and 3-hydroxybenzo(a)pyrene biomarker of exposure using physiologically-based pharmacokinetic modelling in rats.
P2860
Q27303447-A70B0235-590B-4A71-9914-6CAB1FA19AACQ28384756-EB882096-336A-4617-928C-E10707FBE52EQ28595882-39BCF04E-EF48-41C5-A5A5-EE215A0EF063Q28649424-9FE766F1-430A-4DD2-9B0A-0A22F7D94F84Q28651691-0D54C061-C538-4A97-8348-53A3109E3DC0Q34439527-663BC83F-7766-431E-8F40-1D7BD5F5DB3AQ35718047-8D6BE32F-4F97-48B1-A5C3-055079E8F6CAQ36892422-B2408074-BEFD-404A-833B-ED1E16F4468DQ37108795-4C1E53A1-DB95-4F6A-B5E8-6970B75911EFQ39520903-9409F170-7432-4B7B-A796-287E6B0E9563Q41261305-7E6CEC7C-B156-4A2B-B30C-6A29D6AAE219Q52362750-279791B7-373A-4B5B-BABA-8F6B74A2B84FQ54685472-E1B3576D-26C6-47A3-95DE-62E4AD8D939B
P2860
Preliminary physiologically based pharmacokinetic models for benzo[a]pyrene and dibenzo[def,p]chrysene in rodents
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Preliminary physiologically ba ...... enzo[def,p]chrysene in rodents
@ast
Preliminary physiologically ba ...... enzo[def,p]chrysene in rodents
@en
Preliminary physiologically ba ...... enzo[def,p]chrysene in rodents
@nl
type
label
Preliminary physiologically ba ...... enzo[def,p]chrysene in rodents
@ast
Preliminary physiologically ba ...... enzo[def,p]chrysene in rodents
@en
Preliminary physiologically ba ...... enzo[def,p]chrysene in rodents
@nl
prefLabel
Preliminary physiologically ba ...... enzo[def,p]chrysene in rodents
@ast
Preliminary physiologically ba ...... enzo[def,p]chrysene in rodents
@en
Preliminary physiologically ba ...... enzo[def,p]chrysene in rodents
@nl
P2093
P2860
P3181
P1476
Preliminary physiologically ba ...... enzo[def,p]chrysene in rodents
@en
P2093
Arun K Sharma
David E Williams
Gowdahalli Krishnegowda
Jolen J Soelberg
Kim A Anderson
Richard A Corley
Shantu G Amin
Susan Ritger Crowell
P2860
P304
P3181
P356
10.1016/J.TAAP.2011.09.020
P407
P577
2011-12-15T00:00:00Z